O7.5. long-term safety and tolerability of brexpiprazole in patients with schizophrenia

DiscussionTreatment with open-label brexpiprazole 1 –4 mg/day was generally well tolerated for up to 52 weeks in patients with schizophrenia. Further, long-term treatment with brexpiprazole was associated with continued improvement in efficacy measures and functional outcomes.References1. Hasan A et al., World J Biol Psychiatry. 2013;14(1):2 ‒44.2. Lehman AF et al., Am J Psychiatry. 2004;161(2 Suppl):1–56.3. Marder SR et al., Acta Neuropsychiatr. 2016; 16:1–13.
Source: Schizophrenia Bulletin - Category: Psychiatry Source Type: research